Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Recruiting
Observational Study
B-ALL
Hematologic Malignancy
Solid Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 30
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- St. Jude Children's Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is being done to learn more about the short-term and long-term side effects of CAR-T cell therapy. Specifically, researchers want to know how often patients get infections, have delays in recovering blood cell counts and/or have damage to the nervous system.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants must have received an initial systemically-administered CAR T cell infusion within the last 1-3 months (+/- 14 days).
* Initial infusion is defined as the first administration of a CAR T cell product the participant has not previously received OR receipt of a C…
Contacts